Insilico Medicine Unveils Revolutionary GIPR Antagonist ISM1354 for Weight Management #GIPR_Antagonist #Insilico_Medicine #ISM1354

Insilico Medicine Unveils Revolutionary GIPR Antagonist ISM1354 for Weight Management #GIPR_Antagonist #Insilico_Medicine #ISM1354
Insilico Medicine Initiates World’s First Phase III Trial of AI-Driven Drug for IPF #China #Insilico_Medicine #Peking #AI_Drug_Development #Rentosertib
Insilico Medicine's AI-Developed Rentosertib Shows Promise for Biological Age Reversal #United_States #Cambridge #Insilico_Medicine #AI_Drug_Discovery #Rentosertib